Literature DB >> 7691745

Use of transformation to construct antigenic hybrids of the class 1 outer membrane protein in Neisseria meningitidis.

P van der Ley1, J van der Biezen, P Hohenstein, C Peeters, J T Poolman.   

Abstract

The class 1 protein of Neisseria meningitidis is an important component of candidate outer membrane vaccines against meningococcal meningitis. This porin protein contains two variable regions which determine subtype specificity and provide binding sites for bactericidal monoclonal antibodies. To determine the contribution of each of these variable regions in the induction of bactericidal antibodies, a set of isogenic strains differing only in their class 1 epitopes was constructed. This was done by transformation of meningococcal strain H44/76 with cloned class 1 genes and selection of the desired epitope combinations in a colony blot with subtype-specific monoclonal antibodies. When used for the immunization of mice, outer membrane complexes induced bactericidal antibodies only against meningococcal strains sharing at least one of their class 1 epitopes. The results demonstrate that the P1.2 and P1.16 epitopes, normally located in the fourth exposed loop of the protein, efficiently induce bactericidal antibodies independently of the particular sequence in the first variable region. The P1.5 and P1.7 epitopes, normally located in the first exposed loop, were found to induce lower bactericidal titers. Hybrid class 1 outer membrane proteins were constructed by inserting oligonucleotides encoding the P1.7 and P1.16 epitopes into the porA gene. In this way, we obtained a set of strains which carry the P1.5 epitope in loop 1, P1.2 in loop 4, and P1.7 and P1.16 (separately or in combination) in either loop 5 or loop 6. The additional epitopes were found to be exposed at the cell surface. Outer membrane complexes from several of these strains were found to induce a bactericidal response in mice against the inserted epitopes. These results demonstrate that it is feasible to construct meningococcal strains carrying multivalent class 1 proteins in which multiple subtype-specific epitopes are present in different cell surface-exposed loops.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691745      PMCID: PMC281147          DOI: 10.1128/iai.61.10.4217-4224.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway.

Authors:  G Bjune; E A Høiby; J K Grønnesby; O Arnesen; J H Fredriksen; A Halstensen; E Holten; A K Lindbak; H Nøkleby; E Rosenqvist
Journal:  Lancet       Date:  1991-11-02       Impact factor: 79.321

2.  The bacterial porin superfamily: sequence alignment and structure prediction.

Authors:  D Jeanteur; J H Lakey; F Pattus
Journal:  Mol Microbiol       Date:  1991-09       Impact factor: 3.501

3.  Monoclonal antibodies against the 70-kilodalton iron-regulated protein of Neisseria meningitidis are bactericidal and strain specific.

Authors:  A Pettersson; B Kuipers; M Pelzer; E Verhagen; R H Tiesjema; J Tommassen; J T Poolman
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

4.  Outer-membrane PhoE protein of Escherichia coli K-12 as an exposure vector: possibilities and limitations.

Authors:  M Agterberg; H Adriaanse; A van Bruggen; M Karperien; J Tommassen
Journal:  Gene       Date:  1990-03-30       Impact factor: 3.688

5.  Molecular architecture and electrostatic properties of a bacterial porin.

Authors:  M S Weiss; U Abele; J Weckesser; W Welte; E Schiltz; G E Schulz
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

6.  Point mutation in meningococcal por A gene associated with increased endemic disease.

Authors:  B T McGuinness; I N Clarke; P R Lambden; A K Barlow; J T Poolman; D M Jones; J E Heckels
Journal:  Lancet       Date:  1991-03-02       Impact factor: 79.321

7.  Topology of outer membrane porins in pathogenic Neisseria spp.

Authors:  P van der Ley; J E Heckels; M Virji; P Hoogerhout; J T Poolman
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

8.  Class-3 porin protein of Neisseria meningitidis: cloning and structure of the gene.

Authors:  S Butcher; M Sarvas; K Runeberg-Nyman
Journal:  Gene       Date:  1991-08-30       Impact factor: 3.688

9.  Isolation of Neisseria meningitidis mutants deficient in class 1 (porA) and class 3 (porB) outer membrane proteins.

Authors:  J Tommassen; P Vermeij; M Struyvé; R Benz; J T Poolman
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

10.  Comparison of the class 1 outer membrane proteins of eight serological reference strains of Neisseria meningitidis.

Authors:  M C Maiden; J Suker; A J McKenna; J A Bygraves; I M Feavers
Journal:  Mol Microbiol       Date:  1991-03       Impact factor: 3.501

View more
  18 in total

1.  Outer membrane composition of a lipopolysaccharide-deficient Neisseria meningitidis mutant.

Authors:  L Steeghs; H de Cock; E Evers; B Zomer; J Tommassen; P van der Ley
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

2.  Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine.

Authors:  E R van der Voort; P van der Ley; J van der Biezen; S George; O Tunnela; H van Dijken; B Kuipers; J Poolman
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  The Omp85 protein of Neisseria meningitidis is required for lipid export to the outer membrane.

Authors:  Stéphanie Genevrois; Liana Steeghs; Paul Roholl; Jean-Jacques Letesson; Peter van der Ley
Journal:  EMBO J       Date:  2003-04-15       Impact factor: 11.598

4.  Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection.

Authors:  D Martin; N Cadieux; J Hamel; B R Brodeur
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

5.  Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolated in Brazil during 1997--1998: overview and implications for vaccine development.

Authors:  C T Sacchi; A P Lemos; T Popovic; J C De Morais; A M Whitney; C E Melles; L M Brondi; L M Monteiro; M V Paiva; C A Solari; L W Mayer
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

6.  Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity.

Authors:  P van der Ley; L Steeghs; H J Hamstra; J ten Hove; B Zomer; L van Alphen
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

7.  Variable expression of class 1 outer membrane protein in Neisseria meningitidis is caused by variation in the spacing between the -10 and -35 regions of the promoter.

Authors:  A van der Ende; C T Hopman; S Zaat; B B Essink; B Berkhout; J Dankert
Journal:  J Bacteriol       Date:  1995-05       Impact factor: 3.490

8.  Analysis of Neisseria meningitidis class 3 outer membrane protein gene variable regions and type identification using genetic techniques.

Authors:  M C Bash; K B Lesiak; S D Banks; C E Frasch
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

9.  Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine.

Authors:  E Rosenqvist; E A Høiby; E Wedege; K Bryn; J Kolberg; A Klem; E Rønnild; G Bjune; H Nøkleby
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

10.  Proposed standardization of Neisseria meningitidis PorA variable-region typing nomenclature.

Authors:  C T Sacchi; A P Lemos; M E Brandt; A M Whitney; C E Melles; C A Solari; C E Frasch; L W Mayer
Journal:  Clin Diagn Lab Immunol       Date:  1998-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.